Avalo Therapeutics, Inc. Common Stock (NASDAQ: AVTX) last traded at $19.83, up 0.05% on the session. The quote above updates while this page is open; the figures below are drawn from Avalo Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Avalo Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker AVTX. Its market capitalisation is $1.06 billion.
Valuation measures for Avalo Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.06B |
|---|---|
| Enterprise value | $1.02B |
| Price / sales | 18025.13 |
| Price / book | 2.37 |
| Beta | 1.23 |
Trailing-twelve-month figures tagged in Avalo Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $59.0K |
|---|---|
| Net income (TTM) | -$100.33M |
| Operating margin | -154844.07% |
| Return on equity | -22.36% |
| Cash | $85.38M |
Range and volume for AVTX over the past 52 weeks.
| 52-week high | $24.27 |
|---|---|
| 52-week low | $8.65 |
| Volume | 567.4K |
| Average volume | 1.34M |
| Previous close | $19.82 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.